Clinical research and the NIH -- a report card

Article Abstract:

Two doctors who were members of the NIH Director's Panel on Clinical Research between 1995 and 1997 review the panel's recommendations and assess the changes within the NIH and the medical research community since 1995. Topics include spending for clinical research, the clinical-research portfolio, first-time applicants and their renewal rates, new clinical-research grants, reorganization of study sections, training in clinical research, educational-loan relief, and general clinical-research centers.

United States, Financial management, Labor Distribution by Employer, Finance, Statistics, Research grants, Research funding, United States. National Institutes of Health, Company financing

---

Clinical research to clinical practice -- lost in translation?

Article Abstract:

Doctors and professional medical associations and organizations can do more to ensure that the results of medical research are applied in the patient care setting. Doctors can encourage patients to modify certain lifestyle behaviors and prescribe appropriate drugs when necessary. Medical associations can develop practice guidelines and reward doctors who follow them.

Health Care and Social Assistance, HEALTH SERVICES, Health Care Services, Medical & Health Services, Medical care, Medical care (Private)

---

Public registration of clinical trials

Article Abstract:

A comprehensive registration of clinical trials or the public reporting of the results is emphasized. The effects of concealing negative data on medical practice, and the concerns about investigational products and the protection of research subjects are discussed.

Government regulation, Public affairs, Ethics, Analysis, Clinical trials, Ethical aspects, Licensing, certification and accreditation, Research fraud

Similar abstracts:

• Abstracts: Incremental treatment costs in National Cancer Institute-sponsored clinical trials. Pharmacy benefits and the use of drugs by the chronically III
• Abstracts: Ban on intact D&X passes in the Senate. Prescription monitoring on tap in Florida
• Abstracts: Medicare's requirement for research participation as a condition of coverage: Is it ethical? The patents-based pharmaceutical development process: Rationale, problems, and potential reforms
• Abstracts: Primary angioplasty -- enduring the test of time. Primary angioplasty - the strategy of choice. Primary angioplasty for acute myocardial infarction -- is it worth the wait?
• Abstracts: Rx: Canadian drugs. Experts look for ways to lessen impact of drug shortages and discontinuations

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.